Cited by 64Tissue Engineering and Regenerative Medicine3D Printing in Biomedical ResearchNerve injury and regeneration

Development of an apoptosis-assisted decellularization method for maximal preservation of nerve tissue structure

Open access
Cornelison, R.C., Wellman, S.M., Park, J.H., Porvasnik, S.L., Song, Y.H., Wachs, R.A., Schmidt, C.E.·2018·Acta Biomaterialia

Abstract

Preservation of tissue structure is often a primary goal when optimizing tissue and organ decellularization methods. Many current protocols nonetheless rely on detergents that aid extraction of cellular components but also damage tissue architecture. It may be more beneficial to leverage an innate cellular process such as apoptosis and promote cell removal without the use of damaging reagents. During apoptosis, a cell detaches from the extracellular matrix, degrades its internal components, and fragments its contents for easier clearance. We have developed a method that leverages this process to achieve tissue decellularization using only mild wash buffers. We have demonstrated that treating peripheral nerve tissue with camptothecin induced both an early marker of apoptosis, cleaved caspase-3 expression, as well as a late stage marker, TUNEL+ DNA fragmentation. Clearance of the cellular components was then achieved in an apoptosis-dependent manner using a gentle wash in hypertonic phosphate buffered saline followed by DNase treatment. This wash paradigm did not significantly affect collagen or glycosaminoglycan content, but it was sufficient to remove any trace of the cytotoxic compound based on conditioned media experiments. The resulting acellular tissue graft was immunogenically tolerated in vivo and exhibited an intact basal lamina microarchitecture mimicking that of native, unprocessed nerve. Hence, ex vivo induction of apoptosis is a promising method to decellularize tissue without the use of harsh reagents while better preserving the benefits of native tissue such as tissue-specific composition and microarchitecture. Statement of significance Tissue decellularization has expanded the ability to generate non-immunogenic organ replacements for a broad range of health applications. Current technologies typically rely on the use of harsh agents for clearing cellular debris, altering the tissue structure and potentially diminishing the pro-regenerative effects. We have developed a method for effectively, yet gently, removing cellular components from peripheral nerve tissue while preserving the native tissue architecture. The novelty of this process is in the induction of programmed cell death - or apoptosis - via a general cytotoxin, thereby enabling antigen clearance using only hypertonic wash buffers. The resulting acellular nerve scaffolds are nearly identical to unprocessed tissue on a microscopic level and elicit low immune responses comparable to an isograft negative control in a model of subcutaneous implantation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.actbio.2018.07.009

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Achieving complete cellular clearance often necessitates the inclusion of additional surfactants or enzymes, such as DNase, which can eliminate over 95% of DNA when used in conjunction with hypertonic washes.

    “Achieving complete cellular clearance often necessitates the inclusion of additional surfactants or enzymes, such as DNase, which can eliminate over 95% of DNA when used in conjunction with hypertonic washes.”

    From Bioactive scaffolds for tissue engineering: A review of decellularized extracellular matrix applications and innovations (2025) · cites this paper as [39]

    The Results report a 95% reduction in average DNA content when DNase followed a hypertonic wash in apoptosis-treated nerve tissue; the Discussion describes this as >95% DNA removal. The source does not establish that complete cellular clearance generally requires additional surfactants or enzymes, and its reported result depends on prior apoptosis induction. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Combining DNase with detergents can achieve significant DNA clearance rates.

    “Combining DNase with detergents can achieve significant DNA clearance rates.”

    From Bioactive scaffolds for tissue engineering: A review of decellularized extracellular matrix applications and innovations (2025) · cites this paper as [39]

    The Results (Induction of apoptosis facilitates cellular antigen removal; page not available) report a significant reduction in nerve-tissue DNA after DNase treatment, including an average 95% reduction under specified conditions. But the tested combination was DNase with a hypertonic wash after apoptosis induction, not DNase with detergents; the Methods (Wash parameter optimization; page not available) explicitly say the protocol sought to avoid detergents. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Apoptosis-assisted decellularization utilizes agents such as camptothecin to induce cell death and is especially promising for neural tissue and vascular structures.

    “Apoptosis‐assisted decellularization utilizes agents such as camptothecin to induce cell death and is especially promising for neural tissue and vascular structures.”

    From Bioactive scaffolds for tissue engineering: A review of decellularized extracellular matrix applications and innovations (2025) · cites this paper as [39]

    The Introduction and Discussion report that camptothecin induces apoptosis in peripheral nerve tissue and enables decellularization while preserving nerve architecture. The paper does not establish that the method is especially promising for vascular structures; its discussion of cardiovascular tissue concerns a different decellularization method. Page numbers are unavailable in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Although hypertonic solutions are efficient in removing proteins and hypotonic solutions are efficient in removing nuclei and DNA, they may not completely eliminate cellular residues and may require additional treatment to facilitate removal of cellular debris.

    “Although hypertonic solutions are efficient in removing proteins and hypotonic solutions are efficient in removing nuclei and DNA, they may not completely eliminate cellular residues and may require additional treatment to facilitate the removal of cellular debris [117,119,120].”

    From Liver tissue engineering using decellularized scaffolds: Current progress, challenges, and opportunities (2024) · cites this paper as [120]

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • Immersion and agitation constitute a relatively straightforward decellularization method commonly used for thin tissues and smaller organs lacking vascular access.

    “Immersion and agitation constitute a relatively straightforward decellularization method commonly used for thin tissues and smaller organs lacking vascular access, such as the esophagus, small intestine submucosa, urinary bladder, blood vessels, trachea, skin, cornea, and nerve [117,119,120,126,152,[163], [164], [165], [166], [167]].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 45

  1. [1]Kolewe ME, Park H, Gray C, Ye X, Langer R, Freed LE. 3D structural patterns in scalable, elastomeric scaffolds guide engineered tissue architecture. Adv Mater. 2013; 25(32): 4459– 65. 23765688 PMC3954574
  2. [2]Yannas IV. Emerging rules for inducing organ regeneration. Biomaterials. 2013; 34(2): 321– 30. 23092865
  3. [3]Spivey EC, Khaing ZZ, Shear JB, Schmidt CE. The fundamental role of subcellular topography in peripheral nerve repair therapies. Biomaterials 2012 p. 4264– 76. 22425024
  4. [4]Hoffman-Kim D, Mitchel JA, Bellamkonda R V. Topography, Cell Response, and Nerve Regeneration. Annu Rev Biomed Eng. 2010; 12(1): 203– 31. 20438370 PMC3016849
  5. [5]Boriani F, Fazio N, Fotia C, Savarino L, Nicoli Aldini N, Martini L, Zini N, Bernardini M, Baldini N. A novel technique for decellularization of allogenic nerves and in vivo study of their use for peripheral nerve reconstruction. J Biomed Mater Res - Part A. 2017; 105(8): 2228– 40. 28426158
  6. [6]Sridharan R, Reilly RB, Buckley CT. Decellularized grafts with axially aligned channels for peripheral nerve regeneration. J Mech Behav Biomed Mater. 2015; 41: 124– 35. 25460409
  7. [7]Vasudevan S, Huang J, Botterman B, Matloub HS, Keefer E, Cheng J. Detergent-free decellularized nerve grafts for long-gap peripheral nerve reconstruction. Plastic and Reconstructive Surgery. 2014; e201. 25426384 PMC4236362
  8. [8]Hudson TW, Liu SY, Schmidt CE. Engineering an improved acellular nerve graft via optimized chemical processing. Tissue Eng. 2004; 10(9–10): 1346– 58. 15588395
  9. [9]Sondell M, Lundborg G, Kanje M. Regeneration of the rat sciatic nerve into allografts made acellular through chemical extraction. Brain Res. 1998; 795(1–2): 44– 54. 9622591
  10. [11]Crapo PM, Gilbert TW, Badylak SF. An overview of tissue and whole organ decellularization processes. Biomaterials NIH Public Access; 4, 2011 p. 3233– 43. PMC3084613 21296410
  11. [12]Keane TJ, Londono R, Turner NJ, Badylak SF. Consequences of ineffective decellularization of biologic scaffolds on the host response. Biomaterials. 2012; 33(6): 1771– 81. 22137126
  12. [13]Guyette JP, Gilpin SE, Charest JM, Tapias LF, Ren X, Ott HC. Perfusion decellularization of whole organs. Nat Protoc. 2014; 9(6): 1451– 68. 24874812
  13. [14]Faulk DM, Carruthers CA, Warner HJ, Kramer CR, Reing JE, Zhang L, D’Amore A, Badylak SF. The effect of detergents on the basement membrane complex of a biologic scaffold material. Acta Biomater. 2014; 10(1): 183– 93. 24055455 PMC3857635
  14. [15]Katyal S, Lee Y, Nitiss KC, Downing SM, Li Y, Shimada M, Zhao J, Russell HR, Petrini JHJ, Nitiss JL, McKinnon PJ. Aberrant topoisomerase-1 DNA lesions are pathogenic in neurodegenerative genome instability syndromes. Nat Neurosci. 2014; 17(6): 813– 21. 24793032 PMC4074009
  15. [16]Vaseva A V, Marchenko ND, Ji K, Tsirka SE, Holzmann S, Moll UM. P53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell. 2012; 149(7): 1536– 48. 22726440 PMC3383624
  16. [17]Yeung J, Ha TJ, Swanson DJ, Goldowitz D. A Novel and Multivalent Role of Pax6 in Cerebellar Development. J Neurosci. 2016; 36(35): 9057– 69. 27581449 PMC5005719
  17. [18]Elmore S Apoptosis: A Review of Programmed Cell Death. Toxicologic Pathology 6, 2007 p. 495– 516. 17562483 PMC2117903
  18. [19]Siu PM, Tam EW, Teng BT, Pei XM, Ng JW, Benzie IF, Mak AF. Muscle apoptosis is induced in pressure-induced deep tissue injury. J Appl Physiol. 2009; 107(4): 1266– 75. 19644027
  19. [20]Wang MO, Etheridge JM, Thompson JA, Vorwald CE, Dean D, Fisher JP. Evaluation of the in vitro cytotoxicity of cross-linked biomaterials. Biomacromolecules. 2013; 14(5): 1321– 9. 23627804 PMC3670822
  20. [21]O’Neill JD, Freytes DO, Anandappa AJ, Oliver JA, Vunjak-Novakovic GV. The regulation of growth and metabolism of kidney stem cells with regional specificity using extracellular matrix derived from kidney. Biomaterials. 2013; 34(38): 9830– 41. 24074840 PMC3835733
  21. [22]Mukhatyar V, Pai B, Clements I, Srinivasan A, Huber R, Mehta A, Mukhopadaya S, Rudra S, Patel G, Karumbaiah L, Bellamkonda R. Molecular sequelae of topographically guided peripheral nerve repair. Ann Biomed Eng. 2014; 42(7): 1436– 55. 24356852 PMC6516464
  22. [23]Morris EJ, Geller HM. Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: Evidence for cell cycle-independent toxicity. J Cell Biol. 1996; 134(3): 757– 70. 8707853 PMC2120941
  23. [24]Caralt M, Uzarski JS, Iacob S, Obergfell KP, Berg N, Bijonowski BM, Kiefer KM, Ward HH, Wandinger-Ness A, Miller WM, Zhang ZJ, Abecassis MM, Wertheim JA. Optimization and critical evaluation of decellularization strategies to develop renal extracellular matrix scaffolds as biological templates for organ engineering and transplantation. Am J Transplant. 2015; 15(1): 64– 75. 25403742 PMC4276475
  24. [25]Seif-Naraghi SB, Horn D, Schup-Magoffin PJ, Christman KL. Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor. Acta Biomater. 2012; 8(10): 3695– 703. 22750737 PMC3429632
  25. [26]Hudson TW, Zawko S, Deister C, Lundy S, Hu CY, Lee K, Schmidt CE. Optimized acellular nerve graft is immunologically tolerated and supports regeneration. Tissue Eng. 2004; 10(11–12): 1641– 51. 15684673
  26. [27]Harley BA, Spilker MH, Wu JW, Asano K, Hsu HP, Spector M, Yannas IV. Optimal Degradation Rate for Collagen Chambers Used for Regeneration of Peripheral Nerves over Long Gaps In: Cells Tissues Organs. 2004 p. 153– 65. 14745243
  27. [28]Nectow AR, Marra KG, Kaplan DL. Biomaterials for the Development of Peripheral Nerve Guidance Conduits. Tissue Eng Part B Rev. 2012; 18(1): 40– 50. 21812591 PMC3262974
  28. [29]Donnelly DJ, Gensel JC, Ankeny DP, van Rooijen N, Popovich PG. An efficient and reproducible method for quantifying macrophages in different experimental models of central nervous system pathology. J Neurosci Methods. 2009; 181(1): 36– 44. 19393692 PMC2737682
  29. [30]Gaudet AD, Popovich PG, Ramer MS. Wallerian degeneration: Gaining perspective on inflammatory events after peripheral nerve injury. Vol. 8, Journal of Neuroinflammation. 2011. PMC3180276 21878126
  30. [31]Cronce MJ, Faulknor RA, Pomerantseva I, Liu XH, Goldman SM, Ekwueme EC, Mwizerwa O, Neville CM, Sundback CA. In vivo response to decellularized mesothelium scaffolds. J Biomed Mater Res - Part B Appl Biomater. 2018; 106(2): 716– 25. 28323397
  31. [32]Guler S, Aslan B, Hosseinian P, Aydin HM. Supercritical Carbon Dioxide-Assisted Decellularization of Aorta and Cornea. Tissue Eng Part C Methods. 2017; 23(9): 540– 7. 28726559
  32. [33]Assmann A, Struß M, Schiffer F, Heidelberg F, Munakata H, Timchenko E V., Timchenko PE, Kaufmann T, Huynh K, Sugimura Y, Leidl Q, Pinto A, Stoldt VR, Lichtenberg A, Akhyari P. Improvement of the in vivo cellular repopulation of decellularized cardiovascular tissues by a detergent-free, non-proteolytic, actin-disassembling regimen. J Tissue Eng Regen Med. 2017; 11(12): 3530– 43. 28078820
  33. [34]Gillies AR, Smith LR, Lieber RL, Varghese S. Method for Decellularizing Skeletal Muscle Without Detergents or Proteolytic Enzymes. Tissue Eng Part C Methods. 2011; 17(4): 383– 9. 20973753 PMC3065727
  34. [35]Bourgine PE, Pippenger BE, Todorov A, Tchang L, Martin I. Tissue decellularization by activation of programmed cell death. Biomaterials. 2013; 34(26): 6099– 108. 23721795
  35. [36]Bourgine PE, Scotti C, Pigeot S, Tchang LA, Todorov A, Martin I. Osteoinductivity of engineered cartilaginous templates devitalized by inducible apoptosis. Proc Natl Acad Sci. 2014; 111(49): 17426– 31. 25422415 PMC4267331
  36. [38]Traganos F, Seiter K, Feldman E, Halicka HD, Darzynkiewicz Z. Induction of apoptosis by camptothecin and topotecan In: Annals of the New York Academy of Sciences. 1996 p. 101– 10. 8993504
  37. [39]Silva MT. Secondary necrosis: The natural outcome of the complete apoptotic program. FEBS Letters 2010 p. 4491– 9. 20974143
  38. [40]Czubowicz K, Strosznajder R. Ceramide in the Molecular Mechanisms of Neuronal Cell Death. The Role of Sphingosine-1-Phosphate. Mol Neurobiol. 2014; 50(1): 26– 37. 24420784 PMC4181317
  39. [41]Wood LB, Winslow AR, Proctor EA, McGuone D, Mordes DA, Frosch MP, Hyman BT, Lauffenburger DA, Haigis KM. Identification of neurotoxic cytokines by profiling Alzheimer’s disease tissues and neuron culture viability screening. Sci Rep. 2015; 5. PMC4643219 26564777
  40. [42]Xin M, Li R, Xie M, Park D, Owonikoko TK, Sica GL, Corsino PE, Zhou J, Ding C, White MA, Magis AT, Ramalingam SS, Curran WJ, Khuri FR, Deng X. Small-molecule Bax agonists for cancer therapy. Nat Commun. 2014; 5. PMC4172359 25230299
  41. [43]Palchaudhuri R, Lambrecht MJ, Botham RC, Partlow KC, van Ham TJ, Putt KS, Nguyen LT, Kim S-HH, Peterson RT, Fan TM, Hergenrother PJ. A Small Molecule that Induces Intrinsic Pathway Apoptosis with Unparalleled Speed. Cell Rep. 2015; 13(9): 2027– 36. 26655912 PMC4683402
  42. [44]Pommier Y Topoisomerase I inhibitors: Camptothecins and beyond In: Nature Reviews Cancer. 2006 p. 789– 802. 16990856
  43. [45]King AE, Southam KA, Dittmann J, Vickers JC. Excitotoxin-induced caspase-3 activation and microtubule disintegration in axons is inhibited by taxol. Acta Neuropathol Commun. 2013; 1(1): 59. 24252213 PMC3893530
  44. [46]Cusack CL, Swahari V, Hampton Henley W, Michael Ramsey J, Deshmukh M. Distinct pathways mediate axon degeneration during apoptosis and axon-specific pruning. Nat Commun. 2013; 4. PMC4183061 23695670
  45. [47]Ghosh A, Manrique-Hoyos N, Voigt A, Schulz JB, Kreutzfeldt M, Merkler D, Simons M. Targeted ablation of oligodendrocytes triggers axonal damage. PLoS One. 2011; 6(7). PMC3144945 21818378

Cited by

Sorted by citations

Authors
Cornelison, R. C., Wellman, S. M., Park, J. H., Porvasnik, S. L., Song, Y. H., Wachs, R. A., & Schmidt, C. E.
Affiliations
University of Florida (US)
Corresponding author
  • Wachs, R.A.
  • Schmidt, C.E.
Venue
Acta Biomaterialia
Publisher
Elsevier BV
Published
2018-09
Volume
77
Pages
116-126
ISSN
1742-7061 (ISSN-L)
OpenAlex
W2879455943
Cited by
64
References
1
Citations by year
2026: 3 · 2025: 6 · 2024: 18 · 2023: 10 · 2022: 8 · 2021: 9 · 2020: 7 · 2019: 3
FWCI
4.94
Type
journal article
Language
en
Open access
Locations
  • Acta Biomaterialia (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Biomedical Imaging and Bioengineering (R21EB013358)
Topics
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
Keywords
decellularization, apoptosis, peripheral nerves, camptothecin, caspase-3, TUNEL, DNase treatment, tissue architecture preservation, basement membrane, collagen, glycosaminoglycans
MeSH terms
Animals, Basement Membrane, Camptothecin, Detergents, Extracellular Matrix, Glycosaminoglycans, Macrophages, Male, Nerve Tissue, Rats, Inbred Lew, Sciatic Nerve, Rats, Sprague-Dawley, Apoptosis, Peripheral Nervous System, Tissue Engineering, Rats, Caspase 3, DNA Fragmentation, Tissue Scaffolds

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review